IgM+ mBc have been shown to be decreased in patients with systemic lupus erythematosus (SLE) [24], rheumatoid arthritis (RA) [25], and Sjögren's Syndrome [26]. The gene discussed is CD40LG; the disease is systemic lupus erythematosus.